Related Experiment Videos
Novel methods of using proton-pump inhibitors.
1University of Wisconsin Medical School, Aurora Sinai Medical Center, 945 North 12th Street, Room 4040, Milwaukee, WI 53233, USA. nvakil@facstaff.wisc.edu
Gastroenterology Clinics of North America
|December 20, 2002
Summary
On-demand proton pump inhibitor (PPI) therapy offers cost savings for GERD patients without mucosal damage. However, long-term effectiveness and safety, especially for nocturnal symptoms, require further investigation.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Proton pump inhibitors (PPIs) are standard for gastroesophageal reflux disease (GERD).
- On-demand PPI therapy is emerging for nonerosive or mild erosive GERD.
- Long-term data on on-demand PPIs are limited.
Purpose of the Study:
- To evaluate the potential of on-demand PPI therapy for GERD.
- To explore strategies for managing nocturnal reflux symptoms.
- To assess the long-term efficacy and safety of current GERD treatment approaches.
Main Methods:
- Review of current literature on PPI and H2RA therapies for GERD.
- Analysis of data regarding on-demand PPI efficacy and cost-effectiveness.
- Examination of studies on combination therapy for nocturnal acid control.
Main Results:
- On-demand PPIs show cost-effectiveness, particularly in patients without visible esophageal damage.
- Nocturnal acid control may be achieved by combining PPIs with bedtime H2RAs.
- Limited data exist on long-term outcomes and nocturnal symptom management.
Conclusions:
- On-demand PPI therapy is a viable, cost-saving option for select GERD patients.
- Combination therapy with H2RAs at bedtime may help control nocturnal reflux.
- Further research is needed to establish long-term safety and efficacy of these strategies.